Morgan Stanley Maintains Equal-Weight on Incyte, Raises Price Target to $94

Benzinga · 5d ago
Morgan Stanley analyst Vikram Purohit maintains Incyte (NASDAQ:INCY) with a Equal-Weight and raises the price target from $92 to $94.